The authors of the original article “CDKN2A is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma.” (Biosci Rep (2021) 41(10), https://doi.org/10.1042/BSR20211103) would like to correct Table 2. Due to their negligence, they had switched the number of high CDKN2A expression deaths with that of survivals in Table 2. This reversal in figures is corrected in this Correction.

Table 2
Demographic and clinicopathological parameters of patients with hepatocellular carcinoma (data from 35 clinical patients)
Clinicopathological factorNumber of cases(n = 35)CDKN2AP
High expressionLow expression
Age
<55 0.156
≥55 28 19
Gender
Male 20 14 0.892
Female 15 10
TNM stage
I-II 16 11 0.053
III-IV 19 13
I-II 14 10 0.684
III-IV 21 14
Survival status
Death 16 14 0.035
Survival 19 10
Clinicopathological factorNumber of cases(n = 35)CDKN2AP
High expressionLow expression
Age
<55 0.156
≥55 28 19
Gender
Male 20 14 0.892
Female 15 10
TNM stage
I-II 16 11 0.053
III-IV 19 13